Acadia Healthcare Company, Inc.
Close on Oct 19, 2026
- Market cap
- $2.76B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 4, 2026, after market close (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Jul 28, 2026 | After market close | $865.80M | $0.12 | $0.38 |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 29, 2026 | After market close | $828.80M | $0.05 | $0.37 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 25, 2026 | Before market open | $821.50M | $-13.02 | $0.07 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 5, 2025 | After market close | $851.60M | $0.40 | $0.72 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 5, 2025 | After market close | $869.20M | $0.33 | $0.83 |
| Q1 FY2025 Ended Mar 31, 2025 | May 12, 2025 | After market close | $770.50M | $0.09 | $0.40 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 27, 2025 | After market close | $774.20M | $0.35 | $0.64 |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 30, 2024 | After market close | $815.60M | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Jul 31, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 1, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | After market close | – | – | – |
Company guidance
Outlook given with results on Jul 28, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Capital expenditures | Full Year 2026 | $235.00M to $255.00M | Lowered |
| Adjusted EBITDAnon-GAAP | Full Year 2026 | $590.00M to $615.00M | Raised |
| Adjusted earnings per diluted sharenon-GAAP | Full Year 2026 | $1.45 to $1.60 | Raised |
| Operating Cash Flow | Full Year 2026 | $350.00M to $400.00M | Raised |
| Revenue | Full Year 2026 | $3.40B to $3.45B | Raised |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Acadia Healthcare filed with the SEC
IN RE ACADIA HEALTHCARE COMPANY,
Other events · EX-99.1 to Form 8-K
IN RE ACADIA HEALTHCARE COMPANY, INC. STOCKHOLDER DERIVATIVE LITIGATION
Other events · EX-99.2 to Form 8-K
ACADIA HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS AND UPDATES FULL YEAR 2026 FINANCIAL AND CASH FLOW GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
ACADIA HEALTHCARE ANNOUNCES FIRST QUARTER 2026 RESULTS
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
ACADIA HEALTHCARE ANNOUNCES FOURTH QUARTER AND 2025 RESULTS
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99 to Form 8-K
ACADIA HEALTHCARE UPDATES PLGL RESERVES FOLLOWING
Regulation FD disclosure · EX-99 to Form 8-K
ACADIA HEALTHCARE REPORTS THIRD QUARTER 2025 RESULTS
Results of operations · Executive or director change · EX-99 to Form 8-K
ACADIA HEALTHCARE APPOINTS TODD YOUNG AS CHIEF FINANCIAL OFFICER
Executive or director change · Regulation FD disclosure · EX-99 to Form 8-K
ACADIA HEALTHCARE REPORTS SECOND QUARTER 2025 RESULTS
Results of operations · Executive or director change · EX-99 to Form 8-K
ACADIA HEALTHCARE REPORTS FIRST QUARTER 2025 RESULTS
Results of operations · EX-99 to Form 8-K
OF $500 MILLION SENIOR NOTES OFFERING
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K
OF $550 MILLION SENIOR NOTES DUE 2033
Material agreement · New financial obligation · Other events · EX-99.2 to Form 8-K
ACADIA HEALTHCARE REPORTS FOURTH QUARTER 2024 RESULTS
Results of operations · EX-99 to Form 8-K
ACADIA HEALTHCARE REPORTS STRONG THIRD QUARTER 2024 RESULTS
Results of operations · EX-99 to Form 8-K
ACADIA HEALTHCARE REPORTS SECOND QUARTER 2024 RESULTS
Results of operations · EX-99 to Form 8-K
ACADIA HEALTHCARE REPORTS FIRST QUARTER 2024 RESULTS, AFFIRMS FULL YEAR 2024 GUIDANCE
Results of operations · EX-99 to Form 8-K
ACADIA HEALTHCARE REPORTS FOURTH QUARTER 2023 RESULTS
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Reports Third Quarter 2023 Results and Updates Guidance Ranges to Reflect Continued Strong Business Growth and Momentum
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Reports Second Quarter 2023 Results and Raises 2023 Guidance
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Reports First Quarter 2023 Results
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Reports Fourth Quarter 2022 Results
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Provides Business Outlook Ahead of Investor Day
Regulation FD disclosure · EX-99.1 to Form 8-K
CORRECTING and REPLACING Acadia Healthcare Reports Third Quarter 2022 Results
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K/A
Acadia Healthcare Reports Third Quarter 2022 Results
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Reports Second Quarter 2022 Results and Raises 2022 Guidance
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Reports First Quarter 2022 Results
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Reports Fourth Quarter 2021 Results
Results of operations · EX-99 to Form 8-K
Acadia Healthcare Reports Third Quarter 2021 Results
Results of operations · EX-99 to Form 8-K